Literature DB >> 20728705

Developing a cardiology-oncology clinical practice guideline.

Joann Lindenfeld1, Patricia A Kelly.   

Abstract

Clinical Practice Guidelines (CPG) have become an increasingly common method to assist practitioner and patient decisions about health care for specific medical problems. CPGs generally address a single medical diagnosis or syndrome leaving practitioners and patients with little guidance when two major medical diagnoses exist such as in the case of heart disease and cancer. As cancer and heart disease are both diseases of the elderly and share many common risk factors it is likely they will coexist in many patients. Thus screening for and preventing and treating heart disease in the cancer patient assumes increasing importance as aggressive cancer therapies are applied to older patients and as a growing number of cardiovascular side effects of anti-cancer therapy are described. Careful evaluation of heart disease in the cancer patient will likely improve quality of life but may also improve mortality as the presence or development of heart disease may significantly limit life-saving cancer therapies. The rationale, potential problems, and important steps in developing a cardiology-oncology guideline are discussed. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20728705     DOI: 10.1016/j.pcad.2010.06.001

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  5 in total

1.  Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care?

Authors:  Kathryn E Weaver; Randi E Foraker; Catherine M Alfano; Julia H Rowland; Neeraj K Arora; Keith M Bellizzi; Ann S Hamilton; Ingrid Oakley-Girvan; Gretchen Keel; Noreen M Aziz
Journal:  J Cancer Surviv       Date:  2013-02-16       Impact factor: 4.442

2.  Sex Differences Across the Lifespan: A Focus on Cardiometabolism.

Authors:  T Rajendra Kumar; Jane E B Reusch; Wendy M Kohrt; Judith G Regensteiner
Journal:  J Womens Health (Larchmt)       Date:  2020-05-17       Impact factor: 2.681

3.  Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities.

Authors:  Nonniekaye Shelburne; Bishow Adhikari; Joanna Brell; Myrtle Davis; Patrice Desvigne-Nickens; Andrew Freedman; Lori Minasian; Thomas Force; Scot C Remick
Journal:  J Natl Cancer Inst       Date:  2014-09-10       Impact factor: 13.506

4.  Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy.

Authors:  Marijke Wasielewski; Karin Y van Spaendonck-Zwarts; Nico-Derk L Westerink; Jan D H Jongbloed; Aleida Postma; Jourik A Gietema; J Peter van Tintelen; Maarten P van den Berg
Journal:  Open Heart       Date:  2014-07-18

5.  Competing risks of cancer mortality and cardiovascular events in individuals with multimorbidity.

Authors:  Elizabeth A Bayliss; Liza M Reifler; Chan Zeng; Deanna B McQuillan; Jennifer L Ellis; John F Steiner
Journal:  J Comorb       Date:  2014-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.